Encompass Health Corporation

Equities

EHC

US29261A1007

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:02 2024-04-15 pm EDT			5-day change	1st Jan Change
80.73 ^USD	+0.30%		-1.92%	+21.00%

Apr. 11	As You Sow Files an Exempt Solicitation Statement and Request Vote for the Proposal	CI
Apr. 03	Encompass Health Plans to Build 50-Bed Rehabilitation Hospital in San Antonio	MT

Encompass Health : announces date of 2017 fourth quarter conference call

January 29, 2018 at 10:01 am EST

BIRMINGHAM, Ala., Jan. 29, 2018 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced it will report results for its fourth quarter ended Dec. 31, 2017, after the market closes on Feb. 26, 2018. The Company will host an investor conference call at 9 a.m. ET on Feb. 27, 2018, to discuss its results.

(PRNewsfoto/Encompass Health Corporation)

The conference call may be accessed by dialing 877-587-6761 and giving the pass code 2399996. International callers should dial 706-679-1635 and give the same pass code. Please call approximately 10 minutes before the start of the call to ensure you are connected.

A live webcast of the conference call and an online replay of the conference call can be found on the Company's investor website. Currently, investor information can be found at http://investor.healthsouth.com. Beginning Feb. 6, the information can be accessed at http://investor.encompasshealth.com, when the Encompass Health investor website changes in coordination with the Company's new website launch.

About Encompass Health
As a national leader of inpatient rehabilitation hospitals and home-based care, Encompass Health (NYSE: EHC) offers facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that spans 127 hospitals and 237 home health & hospice locations in 36 states and Puerto Rico, the Company is committed to delivering high-quality, cost-effective care across the post-acute continuum. Driven by a set of shared values, Encompass Health is the result of the union between HealthSouth Corporation and Encompass Home Health & Hospice, and is ranked as one of Fortune's 100 Best Companies to Work For, as well as Modern Healthcare's Best Places to Work.

Media Contact:
Casey Lassiter | 205.447.6410
casey.lassiter@encompasshealth.com

Investor Relations Contact:
Crissy Carlisle | 205.970.5860
crissy.carlisle@encompasshealth.com

View original content with multimedia:http://www.prnewswire.com/news-releases/encompass-health-announces-date-of-2017-fourth-quarter-conference-call-300589489.html

SOURCE Encompass Health Corporation

Latest news about Encompass Health Corporation

As You Sow Files an Exempt Solicitation Statement and Request Vote for the Proposal	Apr. 11	CI
Encompass Health Plans to Build 50-Bed Rehabilitation Hospital in San Antonio	Apr. 03	MT
Encompass Health Corp. Announces Preliminary Plans to Build Freestanding, 50-Bed Inpatient Rehabilitation Hospital in San Antonio	Apr. 03	CI
Barclays Raises Price Target on Encompass Health to $101 From $95, Maintains Overweight Rating	Mar. 28	MT
Encompass Health Corporation Appoints Andrew Baird as Senior Vice President of Public Policy, Legislation and Regulations	Mar. 27	CI
Transcript : Encompass Health Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 08:30 AM	Mar. 12
Encompass Health Corp. and Piedmont Announce Plans to Build 40-Bed Inpatient Rehabilitation Hospital in Loganville, Georgia	Mar. 07	CI
Encompass Health Maintains Quarterly Dividend at $0.15 per Share, Payable April 15 to Holders of Record April 1	Feb. 28	MT
Encompass Health Corporation Declares Quarterly Cash Dividend, Payable on April 15, 2024	Feb. 28	CI
Encompass Health to Build 60-Bed Arizona Rehab Hospital for Severe Injury Recovery	Feb. 16	MT
Encompass Health Corporation Announces Preliminary Plans to Build a 60-Bed Inpatient Rehabilitation Hospital in Avondale, Arizona	Feb. 15	CI
UBS Adjusts Encompass Health Price Target to $88 From $84, Maintains Buy Rating	Feb. 09	MT
Mizuho Raises Price Target on Encompass Health to $82 From $77, Keeps Buy Rating	Feb. 09	MT
Deutsche Bank Adjusts Encompass Health Price Target to $83 From $77, Maintains Buy Rating	Feb. 09	MT
Transcript : Encompass Health Corporation, Q4 2023 Earnings Call, Feb 08, 2024	Feb. 08
Encompass Health Q4 Adjusted Earnings, Revenue Rise; 2024 Outlook Set	Feb. 07	MT
Encompass Health Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 07	CI
Earnings Flash (EHC) ENCOMPASS HEALTH Reports Q4 EPS $0.95, vs. Street Est of $0.82	Feb. 07	MT
Earnings Flash (EHC) ENCOMPASS HEALTH Reports Q4 Revenue $1.25B, vs. Street Est of $1.237B	Feb. 07	MT
(EHC) ENCOMPASS HEALTH Sees Fiscal Year 2024 EPS Range $3.77 - $4.06	Feb. 07	MT
(EHC) ENCOMPASS HEALTH Forecasts Fiscal Year 2024 Revenue Range $5.2B - $5.3B	Feb. 07	MT
Encompass Health Corporation Provides Earnings Guidance for the Year 2024	Feb. 07	CI
Encompass Health Corporation Appoints Edward M. Christie III to Its Board of Directors	Nov. 27	CI
Encompass Health Announces the Opening of Encompass Health Rehabilitation Hospital of Fitchburg	Nov. 15	CI
Encompass Health Insider Sold Shares Worth $710,919, According to a Recent SEC Filing	Nov. 14	MT

Chart Encompass Health Corporation

Duration

Period

More charts

Company Profile

Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides specialized rehabilitative treatment on an inpatient basis. It operates hospitals in 37 states and Puerto Rico, with concentrations in Florida and Texas. It operates 161 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The Company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals also treat patients with or recovering from the COVID-19 virus. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.

Sector

Healthcare Facilities & Services

Calendar

2024-04-23 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Encompass Health Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

80.73 USD

Average target price

89.36 USD

Spread / Average Target

+10.69%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
ENCOMPASS HEALTH CORPORATION	+21.00%	8.08B
AIER EYE HOSPITAL GROUP CO., LTD.	-21.62%	15.98B
BANGKOK DUSIT MEDICAL SERVICES	0.00%	11.99B
IHH HEALTHCARE	0.00%	11.11B
APOLLO HOSPITALS ENTERPRISE LIMITED	+10.71%	10.85B
RAMSAY HEALTH CARE LIMITED	-2.15%	7.67B
MOUWASAT MEDICAL SERVICES COMPANY	+24.33%	7.41B
GLOBAL HEALTH LIMITED	+43.91%	4.44B
DALLAH HEALTHCARE COMPANY	-0.81%	4.44B
BURJEEL HOLDINGS PLC	-0.96%	4.27B

Hospitals, Clinics & Primary Care Services